JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis.
Harrison, Claire; Kiladjian, Jean-Jacques; Al-Ali, Haifa Kathrin; Gisslinger, Heinz; Waltzman, Roger; Stalbovskaya, Viktoriya; McQuitty, Mari; Hunter, Deborah S.; Levy, Richard; Knoops, Laurent; Cervantes, Francisco; Vannucchi, Alessandro M.; Barbui, Tiziano; Barosi, Giovanni; New England Journal of Medicine, 2012, vol. 366, issue 9, p 787, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef